tiprankstipranks
Capstone Therapeutics Corp (CAPS)
NASDAQ:CAPS
US Market

Capstone Therapeutics (CAPS) Income Statement

Compare
21 Followers

Capstone Therapeutics Income Statement

Last quarter (Q3 2024), Capstone Therapeutics's total revenue was $12.32M, an increase of 1.98% from the same quarter last year. In Q3, Capstone Therapeutics's net income was $34.00K. See Capstone Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 48.35M$ 61.56M$ 66.74M$ 45.45M$ 0.00
Gross Profit
$ 9.61M$ 16.53M$ 16.32M$ 10.94M$ -39.00K
Operating Expenses
$ 10.87M$ 12.54M$ 11.68M$ 8.54M$ 723.00K
Depreciation and Amortization
$ 306.00K$ 241.00K$ 386.00K$ 245.00K$ 39.00K
EBITDA
$ -1.75M$ 4.23M$ 5.02M$ 2.64M$ -723.00K
Operating Income
$ -1.26M$ 3.99M$ 4.64M$ 2.40M$ -762.00K
Other Income/Expenses
$ -2.33M$ -895.00K$ -279.00K$ -710.00K$ -261.00K
Pretax Income
$ -3.58M$ 3.10M$ 4.36M$ 1.69M$ -1.02M
Net Income
$ -3.82M$ 2.31M$ 3.92M$ 10.46M$ -2.07M
Per Share Metrics
Basic EPS
$ -36.39$ 14.69$ 49.46$ 107.60$ -38.12
Diluted EPS
$ -36.39$ 14.69$ 49.46$ 107.60$ -38.12
Weighted Average Shares Outstanding
157.61K 157.61K 79.28K 79.28K 54.38K
Weighted Average Shares Outstanding (Diluted)
157.61K 157.61K 79.28K 79.28K 54.38K
Currency in USD

Capstone Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis